• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促甲状腺激素受体(TSHR)表达下调与甲状腺癌远处转移相关。

Downregulated expression of TSHR is associated with distant metastasis in thyroid cancer.

作者信息

Liu Tianrun, Men Qianqian, Su Xuan, Chen Weichao, Zou Lan, Li Qiuli, Song Ming, Ouyang Dian, Chen Yanfeng, Li Zhaoqu, Fu Xiaoyan, Yang Ankui

机构信息

Department of Otorhinolaryngology Head and Neck Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510655, P.R. China.

Graceland Medical Center, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510655, P.R. China.

出版信息

Oncol Lett. 2017 Dec;14(6):7506-7512. doi: 10.3892/ol.2017.7122. Epub 2017 Oct 3.

DOI:10.3892/ol.2017.7122
PMID:29344196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5755142/
Abstract

In differentiated thyroid cancer (DTC), the association between thyroid-stimulating hormone receptor (TSHR) and metastasis, and the underlying molecular mechanisms remain unclear. The role of TSHR in the epithelial-mesenchymal transition (EMT) has not yet been reported, to the best of our knowledge. In the present study, the role of TSHR in the distant metastasis of DTC was investigated. TSHR was significantly downregulated in well-differentiated thyroid cancer cells and tissues, and a lack of TSHR promoted thyroid cancer cell invasion and metastasis by inhibiting the EMT of thyroid cancer cells. In addition, the prognostic value of TSHR in thyroid cancer was analyzed. Immunohistochemical analysis of 172 DTC tissues revealed that a lack of expression of TSHR was associated with distant metastasis and a poor survival rate. Multivariate analyses demonstrated that TSHR expression was a significant prognostic factor for distant metastasis and survival time. The results from the present study demonstrated that TSHR inhibits metastasis through regulating EMT , and that a lack of expression of TSHR is a significant independent factor affecting distant metastasis and poor prognosis in DTC.

摘要

在分化型甲状腺癌(DTC)中,促甲状腺激素受体(TSHR)与转移之间的关联以及潜在的分子机制仍不清楚。据我们所知,TSHR在上皮-间质转化(EMT)中的作用尚未见报道。在本研究中,我们探究了TSHR在DTC远处转移中的作用。TSHR在高分化甲状腺癌细胞和组织中显著下调,TSHR的缺失通过抑制甲状腺癌细胞的EMT促进了甲状腺癌细胞的侵袭和转移。此外,我们分析了TSHR在甲状腺癌中的预后价值。对172例DTC组织进行免疫组化分析发现,TSHR表达缺失与远处转移及低生存率相关。多因素分析表明,TSHR表达是远处转移和生存时间的一个重要预后因素。本研究结果表明,TSHR通过调节EMT抑制转移,TSHR表达缺失是影响DTC远处转移和不良预后的一个重要独立因素。

相似文献

1
Downregulated expression of TSHR is associated with distant metastasis in thyroid cancer.促甲状腺激素受体(TSHR)表达下调与甲状腺癌远处转移相关。
Oncol Lett. 2017 Dec;14(6):7506-7512. doi: 10.3892/ol.2017.7122. Epub 2017 Oct 3.
2
Thyroid-stimulating hormone receptor affects metastasis and prognosis in papillary thyroid carcinoma.促甲状腺激素受体影响甲状腺乳头状癌的转移和预后。
Eur Rev Med Pharmacol Sci. 2016 Sep;20(17):3582-91.
3
Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma.BRAF基因和促甲状腺激素受体与甲状腺微小乳头状癌颈部淋巴结转移的相关性
Oncol Lett. 2019 Jan;17(1):183-194. doi: 10.3892/ol.2018.9572. Epub 2018 Oct 12.
4
Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.甲状腺疾病患者外周血中促甲状腺激素受体信使核糖核酸(mRNA)和甲状腺球蛋白mRNA转录物的检测:甲状腺癌的敏感和特异性标志物。
J Clin Endocrinol Metab. 2004 Aug;89(8):3705-9. doi: 10.1210/jc.2003-031967.
5
Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.血液中促甲状腺激素受体信使核糖核酸检测作为循环甲状腺癌细胞的标志物及其在甲状腺癌术前诊断中的作用
J Clin Endocrinol Metab. 2007 Feb;92(2):468-75. doi: 10.1210/jc.2006-2088. Epub 2006 Nov 21.
6
Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal A particle-promoted polypeptide in human breast cancer tissues.促甲状腺激素受体、八聚体结合转录因子4及脑内池A颗粒促进多肽在人乳腺癌组织中的表达
Horm Mol Biol Clin Investig. 2012 Apr;9(3):173-8. doi: 10.1515/hmbci-2011-0130.
7
Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples.循环促甲状腺激素受体 mRNA 作为甲状腺癌的一种新型标志物:来自 1758 个样本的临床应用经验。
Ann Surg. 2010 Oct;252(4):643-51. doi: 10.1097/SLA.0b013e3181f5ba51.
8
Prognosis of Differentiated Thyroid Carcinoma with Initial Distant Metastasis: A Multicenter Study in Korea.初发远处转移的分化型甲状腺癌的预后:韩国的一项多中心研究
Endocrinol Metab (Seoul). 2018 Jun;33(2):287-295. doi: 10.3803/EnM.2018.33.2.287.
9
Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma.循环甲状腺激素受体信使核糖核酸在分化型甲状腺癌随访中并非有效标志物。
Thyroid Res. 2015 Aug 4;8:11. doi: 10.1186/s13044-015-0024-4. eCollection 2015.
10
Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material.利用细胞学材料检测分化型甲状腺癌中促甲状腺激素受体的甲基化状态。
BMC Cancer. 2015 Oct 30;15:824. doi: 10.1186/s12885-015-1861-1.

引用本文的文献

1
TSHR in thyroid cancer: bridging biological insights to targeted strategies.甲状腺癌中的促甲状腺激素受体:将生物学见解与靶向策略相联系
Eur Thyroid J. 2025 Jul 3;14(4). doi: 10.1530/ETJ-24-0369. Print 2025 Aug 1.
2
Serum Biomarkers in Thyroid Malignancies: Evaluating Thyroid-Stimulating Hormone Receptor (TSHR) and Vascular Adhesion Protein-1 (VAP-1) as Potential Diagnostic Biomarker.甲状腺恶性肿瘤中的血清生物标志物:评估促甲状腺激素受体(TSHR)和血管黏附蛋白-1(VAP-1)作为潜在诊断生物标志物的价值。
Asian Pac J Cancer Prev. 2025 Mar 1;26(3):995-1000. doi: 10.31557/APJCP.2025.26.3.995.
3
FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis.纤连蛋白1(FN1)是甲状腺癌可靠的预后生物标志物,与肿瘤免疫及不良预后相关。
Oncol Lett. 2024 Aug 26;28(5):510. doi: 10.3892/ol.2024.14643. eCollection 2024 Nov.
4
Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment.促胃液素抑制素受体 2 和促甲状腺激素受体在嗜酸细胞性甲状腺肿瘤中的表达:对预后和治疗的影响。
Mod Pathol. 2023 Dec;36(12):100332. doi: 10.1016/j.modpat.2023.100332. Epub 2023 Sep 15.
5
PLA2R1 Inhibits Differentiated Thyroid Cancer Proliferation and Migration via the FN1-Mediated ITGB1/FAK Axis.PLA2R1通过FN1介导的ITGB1/FAK轴抑制分化型甲状腺癌的增殖和迁移。
Cancers (Basel). 2023 May 11;15(10):2720. doi: 10.3390/cancers15102720.
6
Development of Novel Murine BRAF-Driven Papillary Thyroid Cancer Cell Lines for Modeling of Disease Progression and Preclinical Evaluation of Therapeutics.开发用于疾病进展建模和治疗药物临床前评估的新型小鼠BRAF驱动的甲状腺乳头状癌细胞系。
Cancers (Basel). 2023 Jan 31;15(3):879. doi: 10.3390/cancers15030879.
7
Biomarker Discovery for Meta-Classification of Melanoma Metastatic Progression Using Transfer Learning.基于迁移学习的黑色素瘤转移进展的元分类的生物标志物发现。
Genes (Basel). 2022 Dec 7;13(12):2303. doi: 10.3390/genes13122303.
8
The Role of and Promoters' Methylation Status for Non-Invasive Detection of Papillary Thyroid Carcinoma.启动子甲基化状态在甲状腺乳头状癌无创检测中的作用
J Clin Med. 2022 Aug 21;11(16):4917. doi: 10.3390/jcm11164917.
9
High Expression of PDE8B and DUOX2 Associated with Ability of Metastasis in Thyroid Carcinoma.PDE8B 和 DUOX2 的高表达与甲状腺癌转移能力相关。
Comput Math Methods Med. 2021 Dec 20;2021:2362195. doi: 10.1155/2021/2362195. eCollection 2021.
10
TGF-β Increases MFGE8 Production in Myeloid-Derived Suppressor Cells to Promote B16F10 Melanoma Metastasis.转化生长因子-β增加髓源性抑制细胞中乳脂肪球表皮生长因子8的产生以促进B16F10黑色素瘤转移。
Biomedicines. 2021 Jul 26;9(8):896. doi: 10.3390/biomedicines9080896.

本文引用的文献

1
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.TERT 启动子突变与甲状腺乳头状癌的远处转移有关。
Eur J Endocrinol. 2015 Apr;172(4):403-13. doi: 10.1530/EJE-14-0837. Epub 2015 Jan 12.
2
Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment.在控制分期和治疗因素时,高分化甲状腺癌的预后指标
Laryngoscope. 2015 Apr;125(4):1021-7. doi: 10.1002/lary.25017. Epub 2015 Jan 13.
3
MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.微小RNA-146b-5p通过靶向锌指富含亮氨酸重复序列蛋白3促进甲状腺癌转移并诱导上皮-间质转化
Cell Physiol Biochem. 2015;35(1):71-82. doi: 10.1159/000369676. Epub 2015 Jan 2.
4
Integrated genomic characterization of papillary thyroid carcinoma.甲状腺乳头状癌的综合基因组特征分析
Cell. 2014 Oct 23;159(3):676-90. doi: 10.1016/j.cell.2014.09.050.
5
Deep sequencing of KIT, MET, PIK3CA, and PTEN hotspots in papillary thyroid carcinomas with distant metastases.对伴有远处转移的甲状腺乳头状癌中KIT、MET、PIK3CA和PTEN热点区域进行深度测序。
Endocr Relat Cancer. 2014 Oct;21(5):L23-6. doi: 10.1530/ERC-14-0361. Epub 2014 Aug 20.
6
The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression.上皮-间质转化标志物PRRX1和miR-146b-5p在甲状腺乳头状癌进展中的作用
Am J Pathol. 2014 Aug;184(8):2342-54. doi: 10.1016/j.ajpath.2014.04.011. Epub 2014 Jun 17.
7
Differentiating the location of cervical lymph node metastasis is very useful for estimating the risk of distant metastases in papillary thyroid carcinoma.区分颈部淋巴结转移的位置对于评估乳头状甲状腺癌远处转移的风险非常有用。
Clin Endocrinol (Oxf). 2014 Oct;81(4):593-9. doi: 10.1111/cen.12463. Epub 2014 May 12.
8
Molecular mechanisms of epithelial-mesenchymal transition.上皮-间质转化的分子机制。
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96. doi: 10.1038/nrm3758.
9
MiR-200, a new star miRNA in human cancer.miR-200,人类癌症中一个新的明星 miRNA。
Cancer Lett. 2014 Mar 28;344(2):166-73. doi: 10.1016/j.canlet.2013.11.004. Epub 2013 Nov 19.
10
The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.miR-200 家族调控 EGF/EGFR 诱导的甲状腺癌细胞上皮间质转化。
Int J Mol Med. 2012 Oct;30(4):856-62. doi: 10.3892/ijmm.2012.1059. Epub 2012 Jul 12.